Cargando…

Multitargeting nature of muscarinic orthosteric agonists and antagonists

Muscarinic receptors (mAChRs) are typical members of the G protein-coupled receptor (GPCR) family and exist in five subtypes from M(1) to M(5). Muscarinic receptor subtypes do not sufficiently differ in affinity to orthosteric antagonists or agonists; therefore, the analysis of receptor subtypes is...

Descripción completa

Detalles Bibliográficos
Autor principal:	Myslivecek, Jaromir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486310/ https://www.ncbi.nlm.nih.gov/pubmed/36148314 http://dx.doi.org/10.3389/fphys.2022.974160

Ejemplares similares

FRET-Based Detection of M(1) Muscarinic Acetylcholine Receptor Activation by Orthosteric and Allosteric Agonists
por: Markovic, Danijela, et al.
Publicado: (2012)

Muscarinic Receptor Agonists and Antagonists
por: Broadley, Kenneth J., et al.
Publicado: (2001)

Differential regulation of muscarinic M(1 )receptors by orthosteric and allosteric ligands
por: Davis, Christopher N, et al.
Publicado: (2009)

The Role of Orthosteric Building Blocks of Bitopic Ligands for Muscarinic M1 Receptors
por: Volpato, Daniela, et al.
Publicado: (2020)

The deletion of M(4) muscarinic receptors increases motor activity in females in the dark phase
por: Valuskova, Paulina, et al.
Publicado: (2018)

Lack of M(4) muscarinic receptors in the striatum, thalamus and intergeniculate leaflet alters the biological rhythm of locomotor activity in mice
por: Riljak, Vladimir, et al.
Publicado: (2020)

Variability in the Drug Response of M(4) Muscarinic Receptor Knockout Mice During Day and Night Time
por: Valuskova, Paulina, et al.
Publicado: (2019)

Structure of CC Chemokine Receptor 2 with Orthosteric and Allosteric Antagonists
por: Zheng, Yi, et al.
Publicado: (2016)

Real-world effects of once-daily inhaled steroid (fluticasone furoate) combined with long-acting beta-2 agonist (vilanterol) and long-acting muscarinic antagonist (umeclidinium) on lung function tests of asthma patients in Japan
por: Umeda, Akira, et al.
Publicado: (2023)

Orthosteric muscarinic receptor activation by the insect repellent IR3535 opens new prospects in insecticide-based vector control
por: Moreau, Eléonore, et al.
Publicado: (2020)

Editorial: Model organisms and experimental models: opportunities and challenges in clinical and translational physiology
por: Myslivecek, Jaromir, et al.
Publicado: (2023)

Autoradiography of (3)H-pirenzepine and (3)H-AFDX-384 in Mouse Brain Regions: Possible Insights into M(1), M(2), and M(4) Muscarinic Receptors Distribution
por: Valuskova, Paulina, et al.
Publicado: (2018)

Investigating the Unbinding of Muscarinic Antagonists from the Muscarinic 3 Receptor
por: Buigues, Pedro J., et al.
Publicado: (2023)

Exploring Non-orthosteric Interactions with a Series of Potent and Selective A(3) Antagonists
por: Miranda-Pastoriza, Darío, et al.
Publicado: (2022)

Internalization of the chemokine receptor CCR4 can be evoked by orthosteric and allosteric receptor antagonists
por: Ajram, Laura, et al.
Publicado: (2014)

Effects of Adrenergic Agonists and Antagonists on Cardiopulmonary Function During Normobaric Hypoxia in Rat
por: Bölter, Christian, et al.
Publicado: (2019)

Discovery of a new class of orthosteric antagonists with nanomolar potency at extrasynaptic GABA(A) receptors
por: Falk-Petersen, Christina Birkedahl, et al.
Publicado: (2020)

The pharmacological rationale for combining muscarinic receptor antagonists and β-adrenoceptor agonists in the treatment of airway and bladder disease()
por: Dale, Philippa R, et al.
Publicado: (2014)

Regulation of the Muscarinic M(3) Receptor by Myocardin-Related Transcription Factors
por: Liu, Li, et al.
Publicado: (2021)

An Orthosteric Inhibitor of the Ras-Sos Interaction
por: Patgiri, Anupam, et al.
Publicado: (2011)

Activation of the Rat α1β2ε GABA(A) Receptor by Orthosteric and Allosteric Agonists
por: Germann, Allison L., et al.
Publicado: (2022)

Contrasting Properties of α7-Selective Orthosteric and Allosteric Agonists Examined on Native Nicotinic Acetylcholine Receptors
por: Gill, JasKiran K., et al.
Publicado: (2013)

5-HT(2C) Receptor Stimulation in Obesity Treatment: Orthosteric Agonists vs. Allosteric Modulators
por: Przegaliński, Edmund, et al.
Publicado: (2023)

Erratum: Regulation of the Muscarinic M(3) Receptor by Myocardin-Related Transcription Factors
por: Frontiers Production Office,
Publicado: (2021)

Effects of a single long-acting muscarinic antagonist agent and a long-acting muscarinic antagonist/long-acting β2-adrenoceptor agonist combination on lung function and symptoms in untreated COPD patients in Japan
por: Yamada, Hideyasu, et al.
Publicado: (2018)

Defining the Molecular Basis for the First Potent and Selective Orthosteric Agonists of the FFA2 Free Fatty Acid Receptor
por: Hudson, Brian D., et al.
Publicado: (2013)

Dopamine and Dopamine-Related Ligands Can Bind Not Only to Dopamine Receptors
por: Myslivecek, Jaromir
Publicado: (2022)

Two Players in the Field: Hierarchical Model of Interaction between the Dopamine and Acetylcholine Signaling Systems in the Striatum
por: Myslivecek, Jaromir
Publicado: (2021)

Social Isolation: How Can the Effects on the Cholinergic System Be Isolated?
por: Myslivecek, Jaromir
Publicado: (2021)

Bitopic ligands: all-in-one orthosteric and allosteric
por: Kamal, Maud, et al.
Publicado: (2009)

Enhancing the Signaling of GPCRs via Orthosteric Ions
por: Chan, H. C. Stephen, et al.
Publicado: (2020)

Optimal Bronchodilation for COPD Patients: Are All Long-Acting β(2)-Agonist/Long-Acting Muscarinic Antagonists the Same?
por: Miravitlles, Marc, et al.
Publicado: (2018)

Effects of (a Combination of) the Beta(2)-Adrenoceptor Agonist Indacaterol and the Muscarinic Receptor Antagonist Glycopyrrolate on Intrapulmonary Airway Constriction
por: Maarsingh, Harm, et al.
Publicado: (2021)

The muscarinic antagonists scopolamine and atropine are competitive antagonists at 5-HT(3) receptors
por: Lochner, Martin, et al.
Publicado: (2016)

Novel long‐acting antagonists of muscarinic ACh receptors
por: Randáková, Alena, et al.
Publicado: (2018)

Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma
por: Aalbers, René, et al.
Publicado: (2017)

DREADD Agonist 21 Is an Effective Agonist for Muscarinic-Based DREADDs in Vitro and in Vivo
por: Thompson, Karen J., et al.
Publicado: (2018)

The Bronchoprotective Effects of Dual Pharmacology, Muscarinic Receptor Antagonist and β(2) Adrenergic Receptor Agonist Navafenterol in Human Small Airways
por: Jude, Joseph Antony, et al.
Publicado: (2023)

Caveolin-1: Functional Insights into Its Role in Muscarine- and Serotonin-Induced Smooth Muscle Constriction in Murine Airways
por: Keshavarz, Maryam, et al.
Publicado: (2017)

Effects of TNFα on Dynamic Cytosolic Ca(2 +) and Force Responses to Muscarinic Stimulation in Airway Smooth Muscle
por: Han, Young-Soo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2rp2afmf3i8nqdh73mdjgmfj1p